Search Results for: CTLA4

27 interactions involving CTLA4 - cytotoxic T-lymphocyte associated protein 4 found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
CD80 CD80 molecule
  • PIP3 activates AKT signaling
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • CD28 co-stimulation
  • CD28 dependent PI3K/Akt signaling
  • CD28 dependent Vav1 pathway
  • CTLA4 inhibitory signaling
  • Interleukin-10 signaling
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Abatacept
  • Galiximab
  • Belatacept
CD86 CD86 molecule
  • PIP3 activates AKT signaling
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • CD28 co-stimulation
  • CD28 dependent PI3K/Akt signaling
  • CD28 dependent Vav1 pathway
  • CTLA4 inhibitory signaling
  • Interleukin-10 signaling
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • Antithymocyte immunoglobulin (rabbit)
  • Abatacept
  • Belatacept
  • Bryostatin 1
AP1M1 adaptor related protein complex 1 subunit mu 1
  • Nef mediated downregulation of MHC class I complex cell surface expression
  • MHC class II antigen presentation
  • Lysosome Vesicle Biogenesis
  • Golgi Associated Vesicle Biogenesis
  • Neutrophil degranulation
TXK TXK tyrosine kinase
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • Fostamatinib
  • Zanubrutinib
CTXN3 cortexin 3
MALL mal, T cell differentiation protein like
TMEM218 transmembrane protein 218

Page 2 out of 2 pages